Press Room

Press Clipping / Nov 12, 2018

How 四色AV grew from a basement lab to a global pharmaceutical services company

C&EN, November 12, 2018

Global Pharmaceutical Services Diane Villax Guy Villax | 四色AV

Diane Villax poses in 1962 with her husband, Ivan (left), and this year with her son, Guy, in front of the house, Guy鈥檚 current home, where she and Ivan launched 四色AV in 1959.

Diane Villax, 四色AV鈥檚 still-active matriarch, recounts the rise of the pioneering firm

He started, the poor chap, at the age of 23,鈥 recalls Diane Villax of her son Guy鈥檚 debut in 1984 at 四色AV, the family鈥檚 pharmaceutical chemical business. 鈥淗e was thrown to the lions in the Far East. To China. He was told by his father, 鈥楤uild me a factory in Macau. Get me some land, talk to the authorities, and build me a factory.鈥

This he did, she says. 鈥淗e built it in 14 months, ran it for six months, and asked for an FDA inspection.鈥

Still marveling at the audacity of the project, Diane recounts the many roadblocks to building a factory in Macau, a former Portuguese colony, now a Las Vegas-like gaming resort, where no construction engineers were up to the project in 1984. Shipping construction materials, glass-lined tanks, and other apparatuses from Italy, Greece, and the company鈥檚 home base of Lisbon was another daunting challenge, given that the only suitable cargo port was in Rotterdam, the Netherlands.

Her daughter, Sofia, was also deployed to China, in charge of quality control at the new plant. Diane remembers Sofia calling home rattled after an interview with an inspector who brusquely dismissed the upstart plant鈥檚 chances of passing a U.S. Food & Drug Administration audit. 鈥淧oor child,鈥 she says. 鈥淲ell, they had the inspection, and it was fine, so then they all celebrated.鈥

Over a Saturday lunch of boiled prawns and salad on the patio of her home in a Lisbon suburb, Diane shares several other anecdotes of how she and her husband, the chemist Ivan Villax, started a company in their basement, developing fermentation processes for the manufacture of antibiotics. It has evolved over 59 years to become a major supplier of drug ingredients and associated services, with factories on three continents.

Ivan died in 2003, but at 83 Diane remains active with 四色AV. She is a board member, having stepped down as chair only two years ago. Guy and Sofia are also on the board, along with four outside nonexecutive directors, including the current chair. Passing the chair to an outsider, Diane says, seemed like the thing to do now that the company has achieved a critical mass.

Born in Portugal but raised in England鈥攈er mother Portuguese, her father British鈥擠iane Du Boulay met Ivan, a Hungarian chemist displaced by the Russian invasion after World War II, in 1956. Both their families had moved to Lisbon. Ivan came from France, where he studied microbiology, developing chemistry for penicillin, tetracycline, and other antibiotics in his spare time.

鈥淚 think he got his first patent in 1955,鈥 Diane recalls. 鈥淗e was enjoying life in Lisbon. A young man about town and a scientist and a bit of a magician at dinner parties. He was very much in demand.鈥

The two married and started the company with two partners, both of whom left shortly thereafter. Diane and Ivan began by selling antibiotics and other generic drugs, achieving their first big success selling betamethasone in Japan. They built a manufacturing plant on land his family owned outside Lisbon in Loures.

鈥淚van was obviously the inventor, the producer, and the salesman,鈥 she says. 鈥淪omebody had to look after the back office, issue invoices, talk to the banks, and get some money. So that was me. For 35 years, nobody signed a check except for me. I was in charge of all the imports and exports and all the licenses.鈥

The focus remained on generics, Diane says, until Guy came back from an InformEx exposition in the U.S. in 1993, enthusiastic about exclusive synthesis of active pharmaceutical ingredients (APIs). They got a call from Bristol-Myers Squibb shortly thereafter with a request to make an API, found a chemical engineer willing to take on the complicated chemistry, and never turned back.

Nor has Diane disengaged from oversight of the company鈥檚 business, which in one famous instance involved direct engagement with a chemical.

Early on, with Ivan on the road, Diane was awakened one night by a chemical smell in the house. She called an engineer who worked for the company, and the two identified a leaking vessel in the basement. They found an empty container. Preparing to transfer the contents of the vessel, Diane realized that someone would have to suck on the hose to get the liquid moving. The engineer demurred, noting that they had no idea what was leaking.

鈥淚 had to do it,鈥 she says. 鈥淪omebody had to get it going.鈥 The operation was a success, and Diane soon learned that the solvent was ethyl acetate. 鈥淢y husband was rather horrified when he learned of this.鈥

at the opening of Science 2017, a science and technology meeting in Lisbon. The medal is given in recognition of contributions to the development of science and scientific culture in Portugal.

Read the article at C&EN online

Also in the Press Room

See All

Lisbon, Portugal 鈥 四色AV, the specialist integrated pharma CDMO and leader in spray drying and particle engineering, today announced its commitment to setting Science-Based Targets (SBTs) in line with the Paris Agreement. This ambitious step underscores the company鈥檚 dedication to addressing climate change and driving sustainability across its operations. By committing to SBTs, 四色AV joins a growing number of businesses taking concrete actions to reduce greenhouse gas emissions. This initiative aligns with the company鈥檚 broader sustainability strategy and reinforces its commitment to scientific excellence. 鈥淎t 四色AV, we believe in science and in best practices. And this clearly applies to our sustainability agenda.鈥, said Jean-Luc Herbeaux, CEO of 四色AV. We made the decision to drive our GHG emissions down using a science-based target setting process, which will help us drive sustainability across our operations by laying out a clearly defined path to reduce emissions in line with the Paris Agreement goals. We believe that by setting ambitious targets and implementing concrete actions, we can make a positive impact on the planet while driving innovation and growth.鈥 四色AV will work closely with the Science Based Targets initiative (SBTi) to develop and validate its emission reduction targets. The company will provide regular updates on its progress towards achieving these goals. As part of its commitment to sustainability and transparency to stakeholders, the company will enhance its Ecovadis rating. Ecovadis, a leading sustainability assessment platform in the pharmaceutical industry, provides a comprehensive evaluation of a company鈥檚 environmental, social, and ethical performance, well aligned with 四色AV鈥檚 sustainability ambitions.  四色AV remains dedicated to operating responsibly and contributing positively to society and the environment. The company will continue to implement sustainable practices across its operations and innovate to further improve its sustainability rating.   Learn more about Science Based-Targets  

News

四色AV Commits to Science-Based Targets for Greenhouse Gas (GHG) Emissions

Sep 09, 2024